Central hypotensive effects of the alpha2a-adrenergic receptor subtype. - Wikidata - awgldk - TriplyDB

Central hypotensive effects of the alpha2a-adrenergic receptor subtype.

Central hypotensive effects of the alpha2a-adrenergic receptor subtype.

http://www.wikidata.org/entity/Q48943949

about

Respective contributions of alpha-adrenergic and non-adrenergic mechanisms in the hypotensive effect of imidazoline-like drugs Heterozygous alpha 2A-adrenergic receptor mice unveil unique therapeutic benefits of partial agonists.Biological significance of agmatine, an endogenous ligand at imidazoline binding sites Peripheral and central effects of circulating catecholamines Cardiovascular effects of rilmenidine, moxonidine and clonidine in conscious wild-type and D79N alpha2A-adrenoceptor transgenic mice alpha(2)-adrenoceptor antagonist properties of OPC-28326, a novel selective peripheral vasodilator alpha(1)-Adrenoceptor subtypes in the mouse mesenteric artery and abdominal aorta Contribution of alpha(2) receptor subtypes to nerve injury-induced pain and its regulation by dexmedetomidine Effect of chronic clonidine treatment on transmitter release from sympathetic varicosities of the guinea-pig vas deferens Clonidine-Induced Heat-Shock Protein Expression in Rat Aorta Intracellular α(2C)-adrenoceptors: storage depot, stunted development or signaling domain?Role of adrenoceptors in the regulation of dopamine/DARPP-32 signaling in neostriatal neurons.Decreased blood pressure response in mice deficient of the alpha1b-adrenergic receptor Alpha2-adrenoceptor-mediated presynaptic inhibition in bulbospinal neurons of rostral ventrolateral medulla.Prototypical imidazoline-1 receptor ligand moxonidine activates alpha2-adrenoceptors in bulbospinal neurons of the RVL.Preclinical evaluation of reconsolidation blockade by clonidine as a potential novel treatment for posttraumatic stress disorder Lack of effect of the alpha2C-adrenoceptor Del322-325 polymorphism on inhibition of cyclic AMP production in HEK293 cells.Antipsychotic pharmacotherapy and orthostatic hypotension: identification and management.Intravenous administration of clonidine reduces intraocular pressure and alters ocular blood flow.The presence of beta2-adrenoceptors sensitizes alpha2A-adrenoceptors to desensitization after chronic epinephrine treatment.Are Alpha-2D Adrenoceptor Subtypes Involved in Rat Mydriasis Evoked by New Imidazoline Derivatives: Marsanidine and 7-Methylmarsanidine?Modulation of alpha2-adrenoceptor functions by heterotrimeric Galphai protein isoforms Desensitization of vascular response in vivo: contribution of genetic variation in the [alpha]2B-adrenergic receptor subtype.Enhanced hypotensive, bradycardic, and hypnotic responses to alpha2-adrenergic agonists in spinophilin-null mice are accompanied by increased G protein coupling to the alpha2A-adrenergic receptor CYP2D6 mediates 4-hydroxylation of clonidine in vitro: implication for pregnancy-induced changes in clonidine clearance [The history of the α-adrenoceptor agonists].α2 adrenergic receptor dysregulation in depressive disorders: implications for the neurobiology of depression and antidepressant therapy The I1-imidazoline receptor: from binding site to therapeutic target in cardiovascular disease Physiological significance of alpha(2)-adrenergic receptor subtype diversity: one receptor is not enough.Analgesic synergy between opioid and α2 -adrenoceptors Possible role of alpha-adrenoceptor subtypes in acute migraine therapy.Synergies at the synapse.Cellular consequences of stress and depression.The antidepressant desipramine is an arrestin-biased ligand at the α(2A)-adrenergic receptor driving receptor down-regulation in vitro and in vivo.Hypertension and the vascular patient.Clonidine and dexmedetomidine produce antinociceptive synergy in mouse spinal cord.Regulation of alpha2AR trafficking and signaling by interacting proteins.Spinophilin Is Indispensable for the α2B Adrenergic Receptor-Elicited Hypertensive Response Antihypertensive effects of selective prostaglandin E2 receptor subtype 1 targeting.Platelet alpha2-adrenoceptor alterations in patients with essential hypertension.

P2860

Q24289306-1B634BC9-253F-42CE-9B18-02BBB8D4EC69 Q24535863-05E8A256-4E7F-461F-AABD-B9A59555FF84 Q24673628-06A2D00F-FED5-4845-83C4-2B62CF8F9FF7 Q28255579-E447788B-97A3-43AD-851D-04CCEBEE64C7 Q28343284-AE3A7A5A-A24F-4675-A535-325ED0CEF4E1 Q28362059-B6A4A953-AF98-4378-8D16-9D15928EEEC8 Q28362738-DEFA43DA-7962-4394-B103-3C39199C395A Q28363081-7C5B3A95-8A71-47C7-AD18-B5CDCE6D34AE Q28365395-20B3CFC2-8890-414A-A574-A65E38F11289 Q28370841-A3790004-C7AB-4AB4-BCDB-8E6F3D047B4D Q28389791-13F98E73-4D52-436E-A689-75EF919C7DB5 Q28395100-624D6850-EC3E-4B1F-9652-FE4CA03E2BE0 Q28504510-6ECFE7DE-F57C-4788-8982-76AF1CCC4B75 Q30304268-50FF83F2-4049-4944-9F3A-377767DBBF65 Q30304692-654683AE-1864-41F4-8506-49CB31483728 Q30446686-C3237D73-EA8A-4E1F-9C17-7B12ED445B2E Q30477206-6ED8499B-3193-4B94-9466-94C7365D06F0 Q33160283-F224C94B-56C0-4DD0-9116-85FD985361E0 Q33286234-29B82C6C-4918-4716-8F5E-B89FD53057E1 Q33311603-AAB7D861-990B-491D-ABA8-8731F03A2478 Q33605237-6F84A0A8-3831-4DB4-A86A-D1B09E3C6BCE Q33762511-0FDAE36D-0D8D-4002-96E1-6487293A1FB0 Q33955008-4043CCBE-05CD-4942-A4B2-7175A01F5FEB Q34051639-B635789B-BEEC-4AAF-AB33-73B9A015C645 Q34127914-5ADEEB65-CCA4-4157-93BF-2E7AF1B685E4 Q34227503-E18BA8C7-A20F-4EA5-BA32-A539747FF368 Q34295208-3493BC8E-6699-412C-BCC4-F458BF83642D Q34314025-DAC8A5DF-DB88-4B6C-8E61-6ECE9034CF1E Q34744859-8E38F041-1A73-42A2-AD8B-4076EC360859 Q34939644-274B59A4-2CE0-447A-92BC-7857D9EEDAB0 Q35115423-7635A4B1-74D8-454B-AA59-99E719B9ED21 Q35117196-7B72394E-1EAC-4955-B53C-33FE4385EC92 Q35236793-0091D388-DB67-4506-9969-C269E61603B9 Q35371943-A1A88EF8-4947-4559-9675-E0D62F94AC8A Q35738465-A01CFC82-8D84-4827-860E-FFFB4690E82C Q35775971-D686759D-B18D-474D-9036-1CA432F50F41 Q35828056-228787AF-E7F8-4BC1-A66D-10029C119DAB Q35921133-8DA41749-9325-44C2-8DFF-8E542760BFCB Q35925625-B8888259-8C41-4209-9644-7FFB88A4BC79 Q36053212-F61798F3-1AD0-4EF4-A671-691EA276E811

P2860

Central hypotensive effects of the alpha2a-adrenergic receptor subtype.

http://www.wikidata.org/entity/Q48943949

description

1996 nî lūn-bûn

@nan

1996年の論文

@ja

1996年学术文章

@wuu

1996年学术文章

@zh

1996年学术文章

@zh-cn

1996年学术文章

@zh-hans

1996年学术文章

@zh-my

1996年学术文章

@zh-sg

1996年學術文章

@yue

1996年學術文章

@zh-hant

name

Central hypotensive effects of the alpha2a-adrenergic receptor subtype.

@en

Central hypotensive effects of the alpha2a-adrenergic receptor subtype.

@nl

type

label

Central hypotensive effects of the alpha2a-adrenergic receptor subtype.

@en

Central hypotensive effects of the alpha2a-adrenergic receptor subtype.

@nl

prefLabel

Central hypotensive effects of the alpha2a-adrenergic receptor subtype.

@en

Central hypotensive effects of the alpha2a-adrenergic receptor subtype.

@nl

P1433

Q48943949-57FE1111-B4E2-4743-9431-839837347FF1

P1476

Q48943949-530A332C-3FB3-449C-ABA7-531765628987

P2093

Q48943949-3378D67A-6982-491D-8B7D-7291ED59008D

Q48943949-541A2DE8-53DF-4E58-85AC-B49A1F3F431D

Q48943949-7770714C-5E93-46E4-A007-89B2A22ED2B3

Q48943949-8ED9DC6A-65D9-46D1-93F9-35AF8C81D19E

Q48943949-B5AD2DA5-AD80-4862-8B42-62E231B03E6F

P304

Q48943949-47D70FD3-BC3B-410B-A1F2-019BF00D0781

P31

Q48943949-2FBA2172-4644-4856-92DF-F7239F46AF65

P356

Q48943949-BB610DD5-7F13-4579-A73C-9AB92B2C65DA

P407

Q48943949-F1EEB67C-8C64-4A46-B94E-EA1DDF0D76CC

P433

Q48943949-F492112F-6544-4155-8E77-5238F8B0C465

P478

Q48943949-47DDDE3F-BC06-4B66-B316-658D4789134F

P577

Q48943949-78258BE1-471E-4ADB-A223-A17610936636

P698

Q48943949-79A26696-41AC-4F95-8AA7-B6D087A026D9

P356

SCIENCE.273.5276.801

P1433

P1476

Central hypotensive effects of the alpha2a-adrenergic receptor subtype.

@en

P2093

Hein L

http://www.w3.org/2001/XMLSchema#string

Limbird LE

http://www.w3.org/2001/XMLSchema#string

MacMillan LB

http://www.w3.org/2001/XMLSchema#string

Piascik MT

http://www.w3.org/2001/XMLSchema#string

Smith MS

http://www.w3.org/2001/XMLSchema#string

P304

801-803

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1126/SCIENCE.273.5276.801

http://www.w3.org/2001/XMLSchema#string

P407

P433

5276

http://www.w3.org/2001/XMLSchema#string

P478

273

http://www.w3.org/2001/XMLSchema#string

P577

1996-08-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

8670421

http://www.w3.org/2001/XMLSchema#string